Alexion Pharmaceuticals Inc (ALXN)
PHARMACEUTICAL PREPARATIONS
Alexion Pharmaceuticals Inc (ALXN) was listed on Nasdaq and stopped trading under the symbol ALXN on July 22, 2021.
- Listed On
- Nasdaq
- Stopped Trading
- July 22, 2021
Institutional ownership
In 13F filings for the quarter ended March 31, 2026, 2 institutions reported holding ALXN, with 16,381 shares worth $2.2 million in aggregate. The largest reported holder was Kentucky Retirement Systems, with 16,188 shares worth $2.2 million. Of the 2 largest holders listed below, 1 opened a new position in ALXN and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Kentucky Retirement Systems | 16,188 | $2M | New position |
| Accent Capital Management | 193 | $7K | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ALXN?
Alexion Pharmaceuticals Inc (ALXN) was listed on Nasdaq and stopped trading under the symbol ALXN on July 22, 2021.
Who are the largest institutional holders of ALXN?
In 13F filings for the quarter ended March 31, 2026, the largest reported holders of ALXN were Kentucky Retirement Systems and Accent Capital Management.
How many institutions own ALXN?
2 institutions reported a position in ALXN for the quarter ended March 31, 2026, worth $2.2 million in total.
Did institutions buy or sell ALXN last quarter?
Of the 2 largest reported holders, 1 opened a new position in ALXN and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ALXN.
Every reported institutional holder, plus insider and congressional trades in ALXN, on SentiSense.